Related Experiment Video
Updated: Feb 20, 2026
09:21
Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
Published on: January 29, 2019
38.0K
Protocol for Efficient Generation and Characterization of Adeno-Associated Viral Vectors
Andreas Jungmann1, Barbara Leuchs2, Jean Rommelaere2
11 Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany, and German Center for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany .
Human Gene Therapy Methods
|October 20, 2017
Summary
We developed a rapid, plasmid-based system for producing high-titer adeno-associated virus vectors in just six days. This versatile method ensures comparability across all serotypes for in vitro and preclinical research.
Area of Science:
- Molecular Biology
- Gene Therapy
- Virology
Background:
- Adeno-associated virus (AAV) vectors are critical for gene transfer.
- Efficient and rapid production of high-quality AAV vectors is essential for research and therapeutic development.
Purpose of the Study:
- To establish a fast and simple plasmid-based production system for adeno-associated virus (AAV) vectors.
- To enable direct comparability of different AAV serotypes using a standardized protocol.
- To generate well-characterized AAV vectors suitable for in vitro and preclinical applications.
Main Methods:
- Development of a plasmid-based AAV production system.
- Optimization of the production protocol for speed and yield.
- Characterization of the produced AAV vectors.
Main Results:
- Achieved high adeno-associated virus titers within 6 working days.
- The protocol is applicable to all AAV serotypes, facilitating direct comparisons.
- Produced well-characterized vectors ready for downstream applications.
Conclusions:
- A simple, fast, and versatile plasmid-based system for high-titer AAV vector production has been established.
- This protocol supports efficient research and preclinical studies by providing comparable, well-characterized vectors.
- The method streamlines AAV vector production, accelerating gene therapy research.
